Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ulcerative colitis: Recent advances in the understanding of disease pathogenesis
Ross J Porter, Rahul Kalla, Gwo–Tzer Ho
F1000Research (2020) Vol. 9, pp. 294-294
Open Access | Times Cited: 199

Showing 1-25 of 199 citing articles:

Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis
Christopher S. Smillie, Moshe Biton, José Ordovás-Montañés, et al.
Cell (2019) Vol. 178, Iss. 3, pp. 714-730.e22
Open Access | Times Cited: 1067
Breaking the therapeutic ceiling in drug development in ulcerative colitis
Dahham Alsoud, Bram Verstockt, Claudio Fiocchi, et al.
˜The œLancet. Gastroenterology & hepatology (2021) Vol. 6, Iss. 7, pp. 589-595
Open Access | Times Cited: 124
The Role of Innate and Adaptive Immune Cells in the Pathogenesis and Development of the Inflammatory Response in Ulcerative Colitis
Aleksandra Kałużna, Paweł Olczyk, Katarzyna Komosińska‐Vassev
Journal of Clinical Medicine (2022) Vol. 11, Iss. 2, pp. 400-400
Open Access | Times Cited: 111
The Anti-Inflammatory and Immunomodulatory Activities of Natural Products to Control Autoimmune Inflammation
Kamal D. Moudgil, Shivaprasad H. Venkatesha
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 95-95
Open Access | Times Cited: 95
Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials
Liuting Zeng, Kailin Yang, Qi He, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Microencapsulation and Probiotic Characterization of Lactiplantibacillus plantarum LM-20: Therapeutic Application in a Murine Model of Ulcerative Colitis
Cynthia Garfias Noguez, Morayma Ramírez Damián, A. Moreno, et al.
Nutrients (2025) Vol. 17, Iss. 5, pp. 749-749
Open Access | Times Cited: 1
Therapeutic Potential of MRGPRX2 Inhibitors on Mast Cells
H. Ogasawara, Masato Noguchi
Cells (2021) Vol. 10, Iss. 11, pp. 2906-2906
Open Access | Times Cited: 57
Natural compounds as safe therapeutic options for ulcerative colitis
Mukta Gupta, Vijay Mishra, Monica Gulati, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 2, pp. 397-434
Open Access | Times Cited: 52
Pathological mechanism and targeted drugs of ulcerative colitis: A review
Meitong Guo, Xiaoyan Wang
Medicine (2023) Vol. 102, Iss. 37, pp. e35020-e35020
Open Access | Times Cited: 25
Network pharmacology mechanisms and experimental verification of licorice in the treatment of ulcerative colitis
Jinrong Kong, Qingzhen Xiang, Wanyue Ge, et al.
Journal of Ethnopharmacology (2024), pp. 117691-117691
Closed Access | Times Cited: 8
Hyaluronic acid-functionalized DDAB/PLGA nanoparticles for improved oral delivery of magnolol in the treatment of ulcerative colitis
Wei Li, Jie Lin, Jie Zhou, et al.
International Journal of Pharmaceutics (2024) Vol. 653, pp. 123878-123878
Closed Access | Times Cited: 7
Mucosal lesions of the upper gastrointestinal tract in patients with ulcerative colitis: A review
Yan Sun, Zhe Zhang, Changqing Zheng, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 22, pp. 2963-2978
Open Access | Times Cited: 51
Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD—What, Why, and How
Claudio Fiocchi, Gabriele Dragoni, Dimitrios Iliopoulos, et al.
Journal of Crohn s and Colitis (2021) Vol. 15, Iss. 9, pp. 1410-1430
Open Access | Times Cited: 44
Gut-microbiota derived bioactive metabolites and their functions in host physiology
Nabendu Debnath, Ravinder Kumar, Ashwani Kumar, et al.
Biotechnology and Genetic Engineering Reviews (2021) Vol. 37, Iss. 2, pp. 105-153
Closed Access | Times Cited: 44
Lactobacillus paracasei R3 protects against dextran sulfate sodium (DSS)-induced colitis in mice via regulating Th17/Treg cell balance
Juan Huang, Ziyan Yang, Yanyun Li, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 43
Procyanidin A1 alleviates DSS-induced ulcerative colitis via regulating AMPK/mTOR/p70S6K-mediated autophagy
Haihua Zhang, Wuying Lang, Xin Liu, et al.
Journal of Physiology and Biochemistry (2022) Vol. 78, Iss. 1, pp. 213-227
Closed Access | Times Cited: 36
Canagliflozin-loaded chitosan-hyaluronic acid microspheres modulate AMPK/NF-κB/NLRP3 axis: A new paradigm in the rectal therapy of ulcerative colitis
Mohamed Nasr, Simona Cavalu, Sameh Saber, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113409-113409
Closed Access | Times Cited: 35
Profound gene expression changes in the epithelial monolayer of active ulcerative colitis and Crohn’s disease
Siri Sæterstad, Ann Elisabet Østvik, Elin Synnøve Røyset, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0265189-e0265189
Open Access | Times Cited: 29
Berberine promotes M2 macrophage polarisation through the IL-4-STAT6 signalling pathway in ulcerative colitis treatment
Kai Xiong, Jia Deng, Tinghui Yue, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e14176-e14176
Open Access | Times Cited: 20
Delivery Strategies of Probiotics from Nano- and Microparticles: Trends in the Treatment of Inflammatory Bowel Disease—An Overview
Sílvio André Lopes, Cesar Augusto Roque‐Borda, Jonatas Lobato Duarte, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2600-2600
Open Access | Times Cited: 19
The role of endoplasmic reticulum stress in regulation of intestinal barrier and inflammatory bowel disease
Yue-Rong Tan, Si-Yang Shen, Haiqing Shen, et al.
Experimental Cell Research (2023) Vol. 424, Iss. 1, pp. 113472-113472
Closed Access | Times Cited: 16
Grape seed proanthocyanidin extract alleviates inflammation in experimental colitis mice by inhibiting NF‐κB signaling pathway
Lei Chu, Shaoru Zhang, Weidong Wu, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 5, pp. 2572-2582
Open Access | Times Cited: 5
Colon targeting in rats, dogs and IBD patients with species-independent film coatings
Francesca Ferraro, Lisa Maria Sonnleitner, Christel Neut, et al.
International Journal of Pharmaceutics X (2024) Vol. 7, pp. 100233-100233
Open Access | Times Cited: 5
Neurobiological Implications of Chronic Stress and Metabolic Dysregulation in Inflammatory Bowel Diseases
Aleksandar Sič, Kiana Cvetkovic, Eshanika Manchanda, et al.
Diseases (2024) Vol. 12, Iss. 9, pp. 220-220
Open Access | Times Cited: 5
Quzhou Aurantii Fructus Flavonoids Ameliorate Inflammatory Responses, Intestinal Barrier Dysfunction in DSS-Induced Colitis by Modulating PI3K/AKT Signaling Pathway and Gut Microbiome
Haiou Wang, Wenkang Huang, Xiaoya Pan, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 1855-1874
Open Access
Page 1 - Next Page

Scroll to top